Top Page
Centrica
(LSE:CNA)
Centrica (CNA) vs. iShares MSCI United Kingdom ETF (EWC)
Centrica Business Overview & Revenue Model
Centrica Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.43B | 19.91B | 26.46B | 23.74B | 14.74B | 12.25B |
| Gross Profit | 5.52B | 4.09B | -1.70B | 9.75B | 1.41B | 3.52B |
| EBITDA | 2.01B | 2.42B | 7.30B | 410.00M | 721.00M | 488.00M |
| Net Income | -118.50M | 1.33B | 3.93B | -782.00M | 586.00M | 41.00M |
Balance Sheet | ||||||
| Total Assets | 16.21B | 18.73B | 21.37B | 29.04B | 27.09B | 17.12B |
| Cash, Cash Equivalents and Short-Term Investments | 5.38B | 6.22B | 6.85B | 4.84B | 5.06B | 1.82B |
| Total Debt | 2.93B | 3.51B | 4.10B | 3.96B | 4.58B | 5.29B |
| Total Liabilities | 12.52B | 13.92B | 17.13B | 27.76B | 24.34B | 15.74B |
| Stockholders Equity | 3.30B | 4.42B | 3.88B | 1.02B | 2.37B | 957.00M |
Cash Flow | ||||||
| Free Cash Flow | 276.00M | 733.00M | 2.42B | 943.00M | 1.19B | 778.00M |
| Operating Cash Flow | 633.00M | 1.15B | 2.75B | 1.31B | 1.61B | 1.27B |
| Investing Cash Flow | -166.00M | 493.00M | 115.00M | -566.00M | 2.26B | -354.00M |
| Financing Cash Flow | -989.00M | -1.55B | -1.41B | -917.00M | -938.00M | -280.00M |
Centrica Technical Analysis
Centrica Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £3.03B | 8.06 | 19.64% | 2.78% | -19.04% | -34.52% | |
76 Outperform | £59.17B | 20.36 | 7.87% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £27.76B | 26.56 | 9.92% | 2.98% | 1.78% | -50.72% | |
66 Neutral | £8.18B | -36.56 | -5.95% | 2.86% | -4.82% | -123.58% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £1.10B | 16.48 | 28.80% | 7.01% | 1.71% | -12.49% | |
58 Neutral | £20.24M | -1.05 | -68.06% | ― | -60.76% | -230.39% |
Centrica Corporate Events
Centrica plc has continued its ongoing share buyback programme, purchasing 1,136,420 ordinary shares on 30 December 2025 at a volume-weighted average price of 169.8045 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the launch of the second tranche of the buyback in late September, the company has repurchased over 140 million shares at a cost of approximately £238 million, bringing its treasury holding to 453.2 million shares and leaving 4.61 billion shares in issue, signalling sustained capital returns to shareholders and active management of its equity base.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued executing the second tranche of its share buyback programme, repurchasing 1,154,459 ordinary shares on 29 December 2025 at an average price of 168.7104 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the buyback’s launch on 22 September 2025, the company has acquired 138,937,301 shares for approximately £235.9 million, leaving 4,612,865,097 shares in issue excluding 452,037,867 shares now held in treasury, underscoring management’s ongoing capital return to shareholders and its active management of the company’s equity base.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has cancelled 35,704,250 ordinary shares previously held in treasury, in line with its policy to keep treasury shares below 10% of total issued share capital. Following the cancellation, the company now holds 450,883,408 ordinary shares in treasury, representing 8.90% of its total issued share capital, with 4,614,019,556 voting rights remaining in issue, a move that modestly adjusts its capital structure and share base for investors.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has disclosed that non-executive directors Philippe Boisseau and Sue Whalley have acquired additional ordinary shares in the company under previously agreed Share Purchase Agreements. The purchases, executed on 29 December 2025 on the London Stock Exchange at £1.6835 per share, involved 1,116 shares for Boisseau and 579 shares for Whalley, signalling continued board-level alignment with shareholder interests through increased personal equity stakes.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has continued executing the second tranche of its share buyback programme, repurchasing 1,156,316 ordinary shares on 24 December 2025 at an average price of 168.8752 pence per share via J.P. Morgan Securities, with the shares to be held in treasury. Since the start of this tranche in September, the company has bought back 137.8 million shares for nearly £234 million, bringing its treasury holding to about 486.6 million shares and reducing the free float to 4.61 billion shares, underscoring an ongoing capital return strategy that may enhance earnings per share and support shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued the second tranche of its share buyback programme with the repurchase of 1,150,322 ordinary shares on 23 December 2025 at an average price of 168.8074 pence per share, with the stock to be held in treasury. Since the programme began on 22 September 2025, the company has bought back a total of 136,626,526 shares for approximately £232 million, leaving 4,615,175,872 shares in issue excluding 485,431,342 shares now held in treasury, underscoring management’s ongoing focus on returning capital to shareholders and actively managing the company’s capital structure.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued to execute the second tranche of its share buyback programme, repurchasing 1,150,354 ordinary shares on 22 December 2025 at an average price of 167.8956 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the launch of this phase of the programme on 22 September 2025, the group has bought back more than 135 million shares for about £230.1 million, leaving 4.62 billion shares in issue (excluding 484.3 million held in treasury), a move that effectively concentrates earnings per share and signals ongoing balance sheet strength and commitment to shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued executing the second tranche of its share buyback programme, repurchasing 1,127,771 ordinary shares on 19 December 2025 at a volume-weighted average price of 168.8858 pence per share through J.P. Morgan Securities, with the stock to be held in treasury. Since the programme’s launch on 22 September 2025, the company has bought back 134,325,850 shares for approximately £228.2 million, bringing its treasury holding to 483,138,586 shares and reducing the free float to 4,617,468,628 shares, a capital management move that can enhance earnings per share and signals continued confidence in its balance sheet to investors.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced a board-level change, with Non‑Executive Director Heidi Mottram stepping down from the Board on 31 December 2025 after serving since January 2020 and playing a key role on the Nominations and Remuneration Committees, as well as chairing the Safety, Environment and Sustainability Committee. Former UK minister Amber Rudd will assume the role of Chair of the Safety, Environment and Sustainability Committee and will join the Nominations Committee from 1 January 2026, a move that underscores Centrica’s continued focus on governance, sustainability oversight and strategic board refreshment as it navigates the evolving energy and regulatory landscape.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has continued the second tranche of its share buyback programme, repurchasing 1,150,079 ordinary shares on 18 December 2025 at a volume-weighted average price of 167.0738 pence per share through J.P. Morgan Securities, with the shares to be held in treasury. Since the current programme began in September, the company has bought back 133,198,079 shares at a cost of about £226.3 million, bringing its treasury holding to 482,010,815 shares and leaving 4,618,596,399 shares in issue, signalling ongoing efforts to return capital to shareholders and manage its capital structure by reducing free-float equity.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a share buyback transaction, repurchasing over 1.16 million shares at an average price of 166.7032 pence as part of its ongoing buyback program initiated in September 2025. This initiative, which has so far involved the repurchase of 132 million shares totaling over £224 million, reflects the company’s commitment to optimizing shareholder value and actively managing its capital allocation strategy.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,136,530 of its own ordinary shares at an average price of 167.5108 pence per share, as part of its ongoing share buyback program. This transaction is part of the second tranche of the buyback initiative, which began on September 22, 2025, and reflects Centrica’s strategy to manage its capital structure effectively. The company now holds 477,074,737 shares in treasury, indicating a significant effort to return value to shareholders and potentially enhance earnings per share.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has announced the sale of Spirit Energy’s remaining 15% interest in the Cygnus gas field and other assets in the Greater Markham Area and Southern North Sea to Serica Energy for approximately £98 million. This transaction aligns with Centrica’s strategy to streamline its portfolio, focus on new investment opportunities, and support the energy transition by investing in projects like the Morecambe Net Zero carbon storage initiative. The sale is expected to complete in the second half of 2026, subject to regulatory approvals.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 6,427,619 of its own ordinary shares at an average price of 165.4532 pence per share, as part of its ongoing share buyback program initiated on 22 September 2025. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with the company having acquired a total of 127,125,471 shares since the program’s inception, costing over £216 million. The shares will be held in treasury, impacting the total number of shares in circulation and potentially influencing the company’s stock price and shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 4,238,678 ordinary shares at a price of 166.2484 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative, which began on 22 September 2025. The company has acquired a total of 120,697,852 shares since the program’s inception, costing approximately £205.5 million. The repurchased shares will be held in treasury, increasing Centrica’s treasury holdings to 469,510,924 shares, while the total number of shares in issue remains at 4,631,096,290. This strategic move is likely to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and providing a return of capital to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £203.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the acquisition of ordinary shares under its Share Incentive Plan by its Executive Directors, Christopher O’Shea and Russell O’Brien. The transactions involved acquiring Partnership and Matching Shares, with a total of 111 and 112 shares acquired by O’Shea and O’Brien, respectively. This move reflects the company’s ongoing commitment to aligning its executives’ interests with shareholder value, potentially impacting its market perception and stakeholder confidence.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £205.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,271,048 of its own ordinary shares at an average price of 167.3014 pence per share, as part of its ongoing share buyback program initiated in September 2025. This move is part of a broader strategy to optimize capital structure and return value to shareholders, with significant implications for the company’s market positioning and shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 3,007,770 of its own ordinary shares at a price of 167.9331 pence per share as part of its ongoing buyback program. This move, executed through J.P. Morgan Securities, is part of the second tranche of the buyback initiative announced in September 2025, reflecting Centrica’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 2,230,475 of its own ordinary shares at an average price of 168.6131 pence per share as part of its ongoing buyback program. This transaction, executed through J.P. Morgan Securities, is part of a larger effort that has seen the company repurchase over 111 million shares since September, reflecting a strategic move to consolidate its share capital and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a significant share buyback, purchasing 1,179,342 of its ordinary shares at an average price of 169.3347 pence per share, as part of its ongoing buyback program initiated in September 2025. This move is part of Centrica’s strategy to manage its capital structure and return value to shareholders, potentially enhancing its market position and signaling confidence in its financial health.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £182.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,145,067 of its own ordinary shares at a price of 170.5181 pence per share, as part of its ongoing share buyback program. This move is part of the second tranche of the buyback initiative, which began on September 22, 2025, and aims to enhance shareholder value by reducing the number of shares in circulation. The company now holds 456,672,936 shares in treasury, impacting its share capital structure and potentially influencing market perceptions and shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,155,019 of its own ordinary shares at a price of 168.8213 pence per share, as part of its ongoing share buyback program. This acquisition is part of the second tranche of the buyback initiative, which began on 22 September 2025, and is aimed at optimizing the company’s capital structure. As a result of this transaction, Centrica now holds 455,527,869 shares in treasury, with 4,645,079,345 shares remaining in circulation. This move is expected to enhance shareholder value and reflects Centrica’s strategic focus on returning capital to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,151,419 of its own ordinary shares at an average price of 169.2431 pence per share, as part of its ongoing share buyback program. This transaction is part of a larger initiative that began in September 2025, aimed at consolidating the company’s share capital and potentially enhancing shareholder value. As a result, Centrica now holds 454,372,850 shares in treasury, with 4,646,234,364 shares remaining in circulation. This move is expected to impact the company’s financial structure and market perception positively.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,137,036 of its own ordinary shares at a price of 170.5484 pence per share, as part of its ongoing share buyback program. This move is part of the second tranche of the buyback initiative, which began on 22 September 2025, and reflects the company’s strategy to enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced its total voting rights as of November 30, 2025, with an issued capital comprising over 5.1 billion ordinary shares. Out of these, approximately 4.65 billion shares have voting rights, which stakeholders can use to determine their notification obligations under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,136,288 of its own ordinary shares at a price of 170.8506 pence each, which will be held as treasury shares. This transaction is part of the second tranche of the company’s buyback program, which has seen a total purchase of 103,181,998 shares since September 2025, costing £176,086,712.21. The buyback program is likely to impact Centrica’s financial structure by potentially increasing shareholder value and optimizing capital allocation.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has completed the acquisition of the Grain LNG terminal in partnership with Energy Capital Partners for £1.5 billion. This strategic investment is part of Centrica’s effort to enhance the UK’s energy security and pivot towards stable infrastructure earnings. The acquisition aligns with Centrica’s broader investment strategy, which includes significant commitments to projects like Sizewell C and the redevelopment of the Rough gas storage facility, contingent on supportive regulatory frameworks.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £198.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a share buyback transaction, purchasing over 1.1 million of its ordinary shares at an average price of 169.6789 pence per share. This purchase is part of the company’s ongoing buyback program, which has seen over 102 million shares bought back since September 2025, reflecting Centrica’s strategy to return value to shareholders and optimize its capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £165.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,189,730 of its own ordinary shares at a price of 163.8691 pence per share, as part of its ongoing share buyback program. This strategic move is part of a larger initiative that began on 22 September 2025, where the company has already acquired over 100 million shares, reflecting a significant investment in its own equity. The repurchased shares will be held as treasury shares, which could potentially enhance shareholder value by reducing the number of shares in circulation and improving earnings per share.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £165.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,198,016 of its own ordinary shares at an average price of 163.6947 pence per share, as part of its ongoing buyback programme. This move, part of a larger initiative that began in September 2025, reflects Centrica’s strategy to manage its capital structure effectively and potentially enhance shareholder value. The company now holds a significant number of shares in treasury, indicating a strong commitment to its buyback strategy, which may impact its market positioning and shareholder relations.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £165.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced that its directors, Philippe Boisseau and Sue Whalley, have acquired ordinary shares in the company as part of their Share Purchase Agreements. These transactions, conducted on the London Stock Exchange, reflect ongoing commitments by the company’s leadership to align their interests with those of shareholders, potentially impacting investor confidence positively.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,240,457 of its own ordinary shares at an average price of 161.7394 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to manage share capital and enhance shareholder value, with significant implications for the company’s financial structure and market perception.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 2,687,766 of its own ordinary shares at an average price of 163.1256 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, reflects Centrica’s strategy to manage its capital structure and return value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 3,681,142 of its own ordinary shares at an average price of 165.0322 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative, aimed at optimizing the company’s capital structure and enhancing shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,715,368 of its own ordinary shares at an average price of 166.3897 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities, is part of a larger initiative that has seen the company repurchase over 88 million shares since September, reflecting a strategic move to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica has announced that Nathan Bostock, currently a Non-Executive Director and Chair of the Audit and Risk Committee, will join Jupiter Fund Management plc as a non-executive director and Chair designate, effective March 2026. Bostock will continue his role at Centrica until July 2026, ensuring a smooth transition while maintaining his current responsibilities. This move highlights Centrica’s ongoing commitment to strong governance and leadership continuity.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has executed a significant share buyback, acquiring over 3 million ordinary shares at an average price of 166.5444 pence per share. This transaction is part of the second tranche of its buyback program, which has seen the company repurchase over 86 million shares since September 2025, reflecting a strategic move to consolidate its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,295,791 of its own ordinary shares at a price of 167.8239 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative that began on 22 September 2025. Since the start of this program, Centrica has acquired over 83 million shares, reflecting a significant investment in its own equity. The move is likely to impact the company’s share value and demonstrates a commitment to returning value to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 6,513,863 of its own ordinary shares at an average price of 168.1454 pence per share, as part of the second tranche of its buyback program. This move, executed through J.P. Morgan Securities, is part of a broader strategy to manage its capital structure and potentially enhance shareholder value. Since the start of the buyback program in September, Centrica has repurchased a total of 81,760,085 shares, reflecting a significant investment in its own equity, which could influence market perceptions and investor confidence.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the cancellation of 78,500,000 ordinary shares previously held in treasury, aligning with its policy to keep treasury shares below 10% of the total issued share capital. This move reduces the number of treasury shares to 8.32% of the total issued share capital, potentially impacting the company’s market positioning and shareholder value by optimizing its capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 3,398,444 of its own ordinary shares at a price of 171.6120 pence per share, as part of its ongoing share buyback program. This purchase is part of the second tranche of the program, which began on 22 September 2025, and aims to enhance shareholder value by reducing the number of shares in circulation. The company has acquired a total of 75,246,222 shares since the program’s inception, reflecting a strategic move to manage its capital structure and potentially increase earnings per share.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc, a leading energy company, has executed a significant share buyback, purchasing 1,881,103 of its own ordinary shares at an average price of 171.9881 pence per share. This transaction is part of the second tranche of its buyback program, which began on September 22, 2025. Since the start of the program, Centrica has acquired a total of 71,847,778 shares, reflecting a strategic move to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 3,545,015 of its own ordinary shares at an average price of 173.0609 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities, is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure, reflecting Centrica’s confidence in its financial stability and future prospects.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the acquisition of ordinary shares under its Share Incentive Plan by two of its executive directors, Christopher O’Shea and Russell O’Brien. This transaction, conducted on 11 November 2025, involved the purchase of Partnership Shares and Matching Shares, reflecting the company’s ongoing commitment to align management interests with shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of over 2 million of its own shares as part of its ongoing buyback program, which began in September 2025. This move, executed through J.P. Morgan Securities, reflects Centrica’s strategy to manage its capital structure and enhance shareholder value, holding a significant number of shares in treasury while maintaining a large number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,960,227 of its own ordinary shares at a price of 174.6643 pence per share, which will be held as treasury shares. This transaction is part of the second tranche of the company’s buyback program, initiated on 22 September 2025, and highlights Centrica’s ongoing strategy to manage its capital structure effectively. Since the start of the buyback program, Centrica has acquired a total of 64,314,289 shares, costing over £110 million. This move is expected to strengthen the company’s financial position and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,256,086 of its own ordinary shares at an average price of 175.9679 pence per share, as part of the second tranche of its buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to repurchase shares, with the company having acquired over 61 million shares since September 2025. This buyback initiative is aimed at consolidating the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,346,087 of its own ordinary shares at a price of 176.6001 pence per share, as part of its ongoing share buyback program. This move, part of a larger buyback initiative announced in September 2025, indicates Centrica’s strategic effort to manage its capital structure and return value to shareholders, potentially impacting the company’s stock market performance and investor relations.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,701,068 of its own ordinary shares at a price of 178.4640 pence per share, which will be held as treasury shares. This purchase is part of the company’s ongoing buyback program, which has seen the acquisition of 56,751,889 shares since September 2025, costing approximately £97.5 million. This strategic move is likely to impact the company’s financial structure and shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and enhancing shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has completed its acquisition of a 15% equity stake in the Sizewell C nuclear power project, marking a significant investment in the UK’s energy future. This investment, totaling £376 million initially and expected to reach £500-600 million by 2028, underscores Centrica’s commitment to delivering zero-carbon power and supporting economic growth and energy security in Britain.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,767,828 of its own ordinary shares at an average price of 179.7894 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to enhance shareholder value and optimize the company’s capital structure, with a total of 55,050,821 shares bought back since September 2025.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced its total voting rights as of October 31, 2025, with a total of 4,697,959,585 shares having voting rights. This figure is essential for shareholders and others with notification obligations to determine their interest in the company under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,630,477 of its own ordinary shares at an average price of 179.2801 pence per share, as part of its ongoing share buyback program. This transaction is part of the second tranche of the buyback initiative, which aims to enhance shareholder value and optimize the company’s capital structure, reflecting Centrica’s strategic focus on financial stability and shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced that its Share Incentive Plan administrators, Equiniti Limited, facilitated the acquisition of ordinary shares through the reinvestment of the company’s 2025 interim dividend. This transaction involved key executives, including Christopher O’Shea and Russell O’Brien, acquiring shares as part of the plan, reflecting the company’s ongoing commitment to aligning management interests with shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,573,220 of its own ordinary shares at a price of 177.8887 pence per share, as part of its ongoing buyback program. This move, executed through J.P. Morgan Securities, is part of a broader strategy to manage the company’s capital structure and enhance shareholder value, reflecting Centrica’s commitment to returning surplus capital to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica PLC has executed a significant share buyback, purchasing over 1.6 million of its ordinary shares at an average price of 176.5474 pence per share. This transaction is part of a larger buyback program initiated in September 2025, reflecting the company’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,977,812 of its own ordinary shares at an average price of 176.1555 pence per share, as part of its ongoing share buyback program. This move is part of the second tranche of the buyback initiative, which began on 22 September 2025, and aims to enhance shareholder value by reducing the number of shares in circulation. The company has so far acquired over 48 million shares, spending approximately £82.75 million. This strategic action is expected to positively impact the company’s market position and shareholder returns.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,739,307 of its own ordinary shares at a price of 177.3822 pence per share, as part of the second tranche of its buyback programme. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with a total of 46,480,889 shares purchased since September 2025 at a cost of over £79 million. The shares will be held in treasury, indicating a strategic approach to enhance shareholder value and optimize the company’s financial flexibility.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £1.85 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced that its directors, Philippe Boisseau and Sue Whalley, have acquired ordinary shares in the company. These transactions, conducted on the London Stock Exchange, were made in accordance with their respective Share Purchase Agreements, reflecting a continued commitment to the company’s growth and stability.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £185.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,755,022 of its own ordinary shares at a price of 178.7104 pence per share, as part of the second tranche of its buyback program. This initiative, which began on 22 September 2025, has seen the company acquire a total of 44,741,582 shares, costing £76,182,953.13. The purchased shares are held as treasury shares, reflecting Centrica’s strategy to manage its capital structure and return value to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £188.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,180,530 of its own ordinary shares at a price of 177.8469 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative announced in September 2025. Since the start of this tranche, Centrica has repurchased a total of 42,986,560 shares, costing over £73 million. The repurchase strategy aims to consolidate shares in treasury, potentially enhancing shareholder value and optimizing the company’s capital structure.
The most recent analyst rating on (GB:CNA) stock is a Hold with a £188.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,110,510 of its own ordinary shares at a price of 175.5673 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities plc, is part of the second tranche of the buyback initiative, which began on 22 September 2025. Since the start of this program, Centrica has acquired over 41 million shares, indicating a strategic move to consolidate its share capital and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,972,764 of its own ordinary shares at an average price of 173.1743 pence per share, as part of its ongoing share buyback program. This move, executed through J.P. Morgan Securities, is part of the second tranche of the program initiated on 22 September 2025. The buyback aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating the company’s confidence in its financial health. This strategic financial maneuver could positively impact shareholder value and market perception.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,109,607 of its own ordinary shares at a price of 174.4321 pence per share, as part of its ongoing buyback program. This transaction, executed through J.P. Morgan Securities, is part of a larger initiative that began on 22 September 2025, with Centrica having acquired a total of 36,255,254 shares at a cost of over £61 million. The shares will be held as treasury shares, which could impact the company’s share value and investor perceptions.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,117,023 of its own ordinary shares at an average price of 174.1858 pence per share, as part of its ongoing share buyback program. This transaction is part of the second tranche of the buyback initiative, which began on September 22, 2025, and aims to enhance shareholder value by reducing the number of shares in circulation. Since the start of the program, Centrica has acquired over 35 million shares, reflecting a significant investment in its own equity, which could potentially improve earnings per share and provide a positive signal to the market.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,107,538 of its own ordinary shares at a price of 171.2271 pence per share, as part of the second tranche of its buyback programme. This move, executed through J.P. Morgan Securities plc, is part of a broader strategy to manage its capital structure and return value to shareholders, having already acquired over 34 million shares since September 2025. The acquisition of these shares, which will be held as treasury shares, reflects Centrica’s ongoing efforts to enhance shareholder value and optimize its financial operations.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,134,778 of its own ordinary shares at an average price of 172.2517 pence per share, as part of the second tranche of its buyback program initiated on 22 September 2025. This strategic move is part of Centrica’s ongoing efforts to manage its capital structure efficiently, potentially impacting shareholder value and market perception positively.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,990,258 of its own ordinary shares at an average price of 168.7173 pence per share, as part of its ongoing share buyback program. This transaction is part of a broader strategy to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share. Since the initiation of the buyback program on 22 September 2025, Centrica has acquired a total of 30,786,308 shares, reflecting a significant investment in its own stock. This move is likely to impact the company’s financial structure and could influence market perceptions positively, signaling confidence in its future performance.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the acquisition of ordinary shares under its Share Incentive Plan by executive directors Christopher O’Shea and Russell O’Brien. The transactions involved the purchase of Partnership Shares and Matching Shares, with a total of 111 and 110 shares acquired respectively, at a price of approximately £1.701 per share. This move highlights Centrica’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially impacting the company’s governance and stakeholder relations.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,223,659 of its own ordinary shares at a price of 169.6995 pence per share, which will be held as treasury shares. This transaction is part of the second tranche of the company’s buyback program initiated on September 22, 2025. Since the start of the program, Centrica has acquired a total of 28,796,050 shares at a cost of £48,488,100.42. This move is expected to impact the company’s share capital structure and could potentially influence shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,772,376 of its own ordinary shares at a price of 170.2164 pence per share, as part of the second tranche of its buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to manage its capital structure, with a total of 26,572,391 shares purchased since September 22, 2025, at a cost of £44,714,562.22. The repurchase of shares is likely to impact the company’s financial metrics and shareholder value, indicating a focus on returning value to shareholders and optimizing its capital allocation.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 2,111,313 of its own ordinary shares at a price of 169.8860 pence per share, as part of its ongoing share buyback program. This transaction, executed through J.P. Morgan Securities, is part of the second tranche of the buyback initiative announced in September 2025. Since the start of this tranche, Centrica has acquired a total of 24,800,015 shares, reflecting a strategic move to consolidate its shareholding and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of over 2 million of its own shares as part of a buyback program, which is a strategy to return value to shareholders and manage capital structure. This move, part of a broader buyback initiative, indicates Centrica’s confidence in its financial health and commitment to enhancing shareholder value, potentially impacting its market positioning positively.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc has announced the purchase of 1,586,292 of its own ordinary shares at an average price of 170.1569 pence per share, as part of the second tranche of its buyback program. This move, executed through J.P. Morgan Securities, is part of a broader strategy to manage capital and potentially enhance shareholder value, reflecting Centrica’s ongoing commitment to optimizing its financial structure.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc, a leading energy and services company, has announced the purchase of 1,657,571 of its own ordinary shares at a price of 169.5757 pence per share. This transaction is part of the second tranche of the company’s buyback program, which was initiated on September 22, 2025. Since the start of the program, Centrica has acquired a total of 19,049,766 shares, reflecting a strategic move to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of over 2 million of its own shares as part of a buyback program, with the shares to be held in treasury. This move is part of a larger strategy initiated in September 2025, aiming to enhance shareholder value and optimize the company’s capital structure. The buyback program reflects Centrica’s confidence in its financial position and its commitment to returning value to shareholders.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of 1,442,483 of its ordinary shares at an average price of 168.9356 pence per share, as part of its ongoing share buyback program. This transaction is part of the second tranche of the buyback initiative, which began on 22 September 2025. Since the start of this tranche, Centrica has acquired over 15 million shares, reflecting a strategic move to enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced its total voting rights as of September 30, 2025, with an issued capital comprising over 5.1 billion ordinary shares. After accounting for shares held in treasury, 4.7 billion shares carry voting rights, which stakeholders can use to determine their notification obligations under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc, a prominent player in the energy sector, has executed a significant share buyback, purchasing over 2 million of its ordinary shares at an average price of 165.3319 pence per share. This move is part of the company’s ongoing buyback program aimed at consolidating its share capital and potentially enhancing shareholder value. The transaction, facilitated by J.P. Morgan Securities plc, reflects Centrica’s strategic financial management and commitment to optimizing its capital structure.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the completion of Spirit Energy’s sale of a 46.25% interest in the Cygnus gas field to Ithaca Energy plc for £116 million. This transaction, which includes the transfer of associated decommissioning liabilities, allows Spirit Energy to retain a 15% stake in the gas field. The sale is expected to impact Centrica’s operations by potentially optimizing its asset portfolio and enhancing its financial position, while also influencing its strategic positioning within the energy industry.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Centrica plc announced the purchase of nearly 2 million of its own ordinary shares as part of its ongoing buyback program. This move, executed through J.P. Morgan Securities, is part of a larger strategy to manage the company’s capital structure and potentially enhance shareholder value. The purchase increases Centrica’s treasury shares to nearly 440 million, reflecting a significant investment in its own equity.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.